CTNM vs STZ · $429.6M cap vs P/E 14, rev $9.14B
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) versus Constellation Brands Inc Class A (STZ) — a side-by-side from cached financials, not a winner call.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
Latest reported STZ revenue for 2026-02-28 was $9.14B. Net income was $1.69B. Revenue was up 322.3% from 2025-02-28 to 2026-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
CTNM currently screens at market cap $429.6M. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Not investment advice. Open the CTNM and STZ stock pages for the full models.
Not investment advice.